SHIELD t3

SHIELD T3 is an organization created by the University of Illinois System as a way to expand the testing of saliva-based COVID-19 that was pioneered by the University of Illinois researchers. SHIELD T3 is working on marketing the innovative COVID-19 testing technology nationwide to encourage widespread testing that produces rapid results in order to limit the spread of COVID-19.

BOARD OF MANAGERS EXECUTIVE COMMITTEE

Bill Jackson, Principal Officer of Shield T3
Donald D. Edwards, Chair
Michael Tokarz, Vice Chair
Dr. Andreas C. Cangellaris

MEETING NOTICES

UPCOMING MEETING DATES/LOCATIONS

SHIELD T3 Board of Managers meets at least twice a year. Special meetings may be called as needed by the Board of Managers. The Executive Committee is also meeting on a regular basis.

Wednesday, August 19th, 2020, 11:00 AM

Meeting Agenda Meeting Notes

Monday, September 28th, 2020, 3:00 PM

Meeting Agenda Meeting Notes

Thursday, October 15th, 2020, 11:00 AM

Meeting Agenda Meeting Notes

Thursday, October 22nd, 2020, 11:00 AM

Meeting Agenda Meeting Notes

Friday, October 30th, 2020 10:00 AM

Meeting Agenda Meeting Notes

Thursday, November 5th, 2020, 11:00 AM

Meeting Agenda Meeting Notes